July 10 — Novo Nordisk China said the NMPA approved a label update for oral semaglutide tablets (brand: Rybelsus). The drug, approved in China for glycaemic control in adults with type 2 diabetes, had its label revised based on the SOUL trial primary

2026-07-10

July 10 — Novo Nordisk China said the NMPA approved a label update for oral semaglutide tablets (brand: Rybelsus). The drug, approved in China for glycaemic control in adults with type 2 diabetes, had its label revised based on the SOUL trial primary results, which showed a 14% reduction in major adverse cardiovascular events (MACE) in adults with type 2 diabetes and established cardiovascular disease and/or chronic kidney disease.

Other News
2026-07-10

1. Federal Reserve's Logan: Voluntary central clearing mechanism may improve the efficiency of open market operations. 2. New York Fed President: It's unclear how much further the Fed's balance sheet can shrink. 3. Institution: Emerging market sove

2026-07-09

Pakistani government sources say Pakistan and Qatar have established new contact channels with the US and Iran aimed at stopping military action and pressing both sides to resume talks under the Islamabad memorandum. Despite a fresh escalation in hos